Search Results

David Moore

REFERENCE: N Engl J Med 355: 1539-50
DAVID MOORE, Imperial College, London and Lima
A new test for TB (reported in the New England Journal of Medicine) has proved more powerful, faster and yet cheaper than any alternative. David Moore explains how the Microscopic-Observation Drug-Susceptibility (MODS) Assay is highly sensitive and specific, and also yields drug susceptibility data.

Mishal Khan

REFERENCE: The Lancet 2007; 369:1955-1960
MISHAL KHAN, London School of Hygiene and Tropical Medicine
Improving on notoriously low TB detection rates in resource-limited parts of the world may be easily achieved, according to Mishal Khan. The effectiveness of screening can be strengthened by giving comprehensive instructions to women before they produce sputum for testing.

Nicholas Grassly

REFERENCE: Lancet 2007; 369:1356-62
NICHOLAS GRASSLY, Imperial College London
A monovalent vaccine for type 1 polio has been tested in India where the virus persists, Nicholas Grassly explains why he thinks the vaccine will be much more effective than the trivalent vaccine.

Lisa McNally

REFERENCE: The Lancet 2007; 369:1440-1451
LISA McNALLY, Institute of Child Health, London, and University of KwaZulu-Natal, Durban
With pneumonia the leading cause of child mortality, treatment needs to be flawless. But recent research reveals that current WHO guidelines need to be revised, according to investigator, Lisa McNally.